Riva Pharma Chairperson Amal Saad El-Din Receives Honor for Driving Egyptian Pharmaceutical Exports

The Medical Export Council has officially honored Riva Pharma in recognition of its outstanding success in expanding its export operations and opening new markets for Egyptian pharmaceuticals. The ceremony was held in the presence of the Chairman of the Egyptian Drug Authority to celebrate the company’s contributions to the sector.

Mrs. Amal Saad El-Din, Chairperson and Managing Director of Riva Pharma, received the honorary award on behalf of the company. This recognition highlights her distinguished leadership in steering the company toward new regional and international markets. These efforts have significantly enhanced the competitive edge of Egyptian medicine and contributed to a substantial increase in total export volumes.

This honor was presented as part of the Medical Export Council’s ongoing initiatives to support exporters within the medical industries sector. These efforts are designed to overcome obstacles facing national companies and empower them to enter new markets, particularly across Africa and the Middle East, as part of a comprehensive national strategy to maximize Egyptian exports.

The award further reflects Riva Pharma’s unwavering commitment to international quality standards and its ability to increase the value-added component of pharmaceutical manufacturing. Through these achievements, the company continues to bolster the national economy and solidify the prestigious standing of the Egyptian pharmaceutical industry in the global marketplace.

‍